Akoya Biosciences Inc

NASDAQ:AKYA   2:22:39 PM EDT
12.24
-0.09 (-0.73%)
Positive Earnings Pre-Announcement

Akoya Reports Third Quarter Results, Raises Full Year 2022 Revenue Guidance

Published: 11/07/2022 22:29 GMT
Akoya Biosciences Inc (AKYA) - Akoya Reports Record Revenue With 40% Yoy Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance.
Q3 Revenue Rose 40 Percent to $18.9 Million.
Raising Its Full Year 2022 Revenue Guidance Range to $73 Million -$75 Million.
Qtrly Net Loss per Share $0.47.
Q3 Earnings per Share View $-0.44, Revenue View $17.7 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $72.3 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $20.06 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $20.04 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.